CAS: 137090-44-9 - 4-(Chloromethyl)-2-(4-methylphenyl)-5-methyloxazole
Formula:C12H12ClNO
InChI:InChI=1S/C12H12ClNO/c1-8-3-5-10(6-4-8)12-14-11(7-13)9(2)15-12/h3-6H,7H2,1-2H3
InChI key:InChIKey=DQTOUJFUSUPWOK-UHFFFAOYSA-N
SMILES:ClCC=1N=C(OC1C)C=2C=CC(=CC2)C
- Synonyms:
- Oxazole, 4-(chloromethyl)-5-methyl-2-(4-methylphenyl)-
- 4-(Chloromethyl)-2-(4-methylphenyl)-5-methyloxazole
- 4-Chloromethyl-5-methyl-2-p-tolyloxazole
- 4-Chloromethyl-5-methyl-2-(4-methylphenyl)oxazole
- 4-(Chloromethyl)-5-methyl-2-(4-methylphenyl)oxazole
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Oxazole, 4-(chloromethyl)-5-methyl-2-(4-methylphenyl)- REF: IN-DA0012U2CAS: 137090-44-9 | 95% | 129.00 €~314.00 € | Wed 22 Jan 25 | |
4-(chloromethyl)-5-methyl-2-(4-methylphenyl)-1,3-oxazole REF: 10-F309311CAS: 137090-44-9 | 95.0% | To inquire | Mon 03 Feb 25 | |
4-(Chloromethyl)-5-methyl-2-(4-methylphenyl)-1,3-oxazole REF: 3D-MFA09044CAS: 137090-44-9 | Min. 95% | - - - | Discontinued product |
Oxazole, 4-(chloromethyl)-5-methyl-2-(4-methylphenyl)-
CAS:137090-44-9
Formula:
C12H12ClNO
Purity:
95%
Molecular weight:
221.6828
Ref: IN-DA0012U2
1g | 314.00 € | ||
100mg | 129.00 € | ||
250mg | 162.00 € | ||
500mg | 223.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
4-(chloromethyl)-5-methyl-2-(4-methylphenyl)-1,3-oxazole
CAS:137090-44-9
Purity:
95.0%
Color and Shape:
Solid
Molecular weight:
221.67999267578125
Ref: 10-F309311
1g | To inquire | ||
100mg | To inquire | ||
250mg | To inquire | ||
500mg | To inquire |
Estimated delivery in United States, on Monday 3 Feb 2025
4-(Chloromethyl)-5-methyl-2-(4-methylphenyl)-1,3-oxazole
CAS:137090-44-9
Versatile small molecule scaffold
Formula:
C12H12ClNO
Purity:
Min. 95%
Molecular weight:
221.68 g/mol
Ref: 3D-MFA09044
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
10g | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |